Is Alkermes plc (ALKS) a Buy, Sell, or Hold?
Alkermes plc
NASDAQ:ALKS
$50.9014 USD
-$0.7 (-1.35%)
- Volume
- 51.98K
- Average Volume
- 2.22M
- Market Capitalization
- $8.48B
- P/E Ratio
- 54.73
- Dividend Yield
- 0.00%
- Price Target
- $54.00
- Year High
- $55.67
- Year Low
- $25.17
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.27
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
78
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
102
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 661.73K
ALKS Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
ALKS Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-07-06 | S-Sale | 54.03 | 2026-07-06 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-07-01 | M-Exempt | 19.34 | 2026-07-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-07-01 | S-Sale | 51.4613 | 2026-07-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-07-01 | S-Sale | 52.1314 | 2026-07-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-07-01 | M-Exempt | 19.34 | 2026-07-01 |
| Wright Christopher I | director | 2026-06-12 | S-Sale | 45.1 | 2026-06-12 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-06-04 | S-Sale | 43.05 | 2026-06-04 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-06-01 | M-Exempt | 19.34 | 2026-06-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-06-01 | S-Sale | 41.6715 | 2026-06-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-06-01 | M-Exempt | 19.34 | 2026-06-01 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-05-29 | M-Exempt | 19.34 | 2026-05-29 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-05-29 | M-Exempt | 19.34 | 2026-05-29 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-05-29 | M-Exempt | 20.03 | 2026-05-29 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-05-29 | S-Sale | 42.3634 | 2026-05-29 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-05-29 | M-Exempt | 20.03 | 2026-05-29 |
| Wright Christopher I | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Wright Christopher I | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| Wright Christopher I | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| Wright Christopher I | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Wright Christopher I | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Wilson Frank Anders | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Wilson Frank Anders | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| Wilson Frank Anders | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| Wilson Frank Anders | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Wilson Frank Anders | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| snyderman nancy lynn MD | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| snyderman nancy lynn MD | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| snyderman nancy lynn MD | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| snyderman nancy lynn MD | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| snyderman nancy lynn MD | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| MCKEON BRIAN P | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| MCKEON BRIAN P | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| MCKEON BRIAN P | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| MCKEON BRIAN P | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| MCKEON BRIAN P | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Lurker Nancy | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Lurker Nancy | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| Lurker Nancy | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| Lurker Nancy | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Lurker Nancy | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| LAURENCIN CATO T | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| LAURENCIN CATO T | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| LAURENCIN CATO T | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| LAURENCIN CATO T | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| LAURENCIN CATO T | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| GAYNOR RICHARD | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| GAYNOR RICHARD | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| GAYNOR RICHARD | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| GAYNOR RICHARD | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| GAYNOR RICHARD | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Cooke Shane | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Cooke Shane | director | 2026-05-21 | F-InKind | 36.95 | 2026-05-22 |
| Cooke Shane | director | 2026-05-20 | A-Award | 36.98 | 2026-05-22 |
| Cooke Shane | director | 2026-05-20 | A-Award | 0 | 2026-05-22 |
| Cooke Shane | director | 2026-05-21 | M-Exempt | 0 | 2026-05-22 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-05-04 | S-Sale | 33.2 | 2026-05-04 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-05-01 | M-Exempt | 19.34 | 2026-05-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-05-01 | S-Sale | 33.3955 | 2026-05-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-05-01 | M-Exempt | 19.34 | 2026-05-01 |
| Lurker Nancy | director | 2026-04-11 | M-Exempt | 0 | 2026-04-13 |
| Lurker Nancy | director | 2026-04-11 | F-InKind | 33.36 | 2026-04-13 |
| Lurker Nancy | director | 2026-04-11 | M-Exempt | 0 | 2026-04-13 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-04-06 | S-Sale | 34.57 | 2026-04-06 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-04-01 | M-Exempt | 19.34 | 2026-04-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-04-01 | S-Sale | 35.5116 | 2026-04-01 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-04-01 | M-Exempt | 19.34 | 2026-04-01 |
| Reed Joshua | officer: SVP, Chief Financial Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Reed Joshua | officer: SVP, Chief Financial Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| POPS RICHARD F | director, officer: Director and CEO, Alkermes plc | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-03-02 | S-Sale | 29.29 | 2026-03-04 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | 2026-03-02 | S-Sale | 30 | 2026-03-04 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-03-02 | M-Exempt | 19.34 | 2026-03-04 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-03-02 | S-Sale | 29.7206 | 2026-03-04 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-03-02 | M-Exempt | 19.34 | 2026-03-04 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-03-02 | S-Sale | 29.29 | 2026-03-04 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-03-03 | S-Sale | 29.76 | 2026-03-04 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-02-26 | F-InKind | 30.73 | 2026-02-27 |
| Parisi Samuel Joseph | officer: VP, Finance (Interim PAO) | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | 2026-02-26 | F-InKind | 30.73 | 2026-02-27 |
| Nichols Christian Todd | officer: SVP, Chief Commercial Officer | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | 2026-02-26 | F-InKind | 30.73 | 2026-02-27 |
| Jackson Blair Curtis | officer: EVP, Chief Operating Officer | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-02-26 | F-InKind | 30.73 | 2026-02-27 |
| Hopkinson Craig C. | officer: EVP R&D, Chief Medical Officer | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-02-26 | M-Exempt | 0 | 2026-02-27 |
| Gaffin David Joseph | officer: EVP, CLO, Alkermes, Inc. | 2026-02-26 | F-InKind | 30.73 | 2026-02-27 |